Treatment regimens of classical and newer taxanes Markus Joerger Review Article 20 November 2015 Pages: 221 - 233
Metformin and pancreatic cancer: Is there a role? Andre De SouzaKhadija Irfan KhawajaMuhammad Wasif Saif Review Article 06 January 2016 Pages: 235 - 242
Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study Hiroaki NagamatsuShuji SumieTakuji Torimura Original Article 11 January 2016 Pages: 243 - 250
A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects Sabiha A. MondalMahmoud AssafEdward O’Mara Original Article 11 January 2016 Pages: 251 - 258
In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine Tamer E. FandyInas AbdallahHazem E. Hassan Original Article 14 December 2015 Pages: 259 - 267
Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes Qian LinKai-Li MaoCui-Tao Lu Original Article 14 December 2015 Pages: 269 - 280
Validity of new methods to evaluate renal function in cancer patients treated with cisplatin Yohei FunakoshiYutaka FujiwaraHironobu Minami Original Article Open access 20 January 2016 Pages: 281 - 288
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents Michela CasanovaEnis ÖzyarAli Varan Original Article 14 December 2015 Pages: 289 - 298
A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin Neeraj AgarwalJordan P. McPhersonSunil Sharma Original Article 30 December 2015 Pages: 299 - 308
Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity Aya GalalWesam M. El-BaklyEbtehal El-Demerdash Original Article 16 December 2015 Pages: 309 - 322
A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice Venúcia B. M. PereiraAnielle T. MeloRoberto C. P. Lima-Júnior Original Article 14 December 2015 Pages: 323 - 332
A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis Jennifer R. EadsJan H. BeumerNeal J. Meropol Original Article 21 December 2015 Pages: 333 - 338
Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma Dong-Hoe KooInkeun ParkJae-Lyun Lee Original Article 21 December 2015 Pages: 339 - 347
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines Shunan YeJacson ShenZhenfeng Duan Original Article 23 December 2015 Pages: 349 - 356
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases Fu SiqingKirk S. CulottaRazelle Kurzrock Original Article 23 December 2015 Pages: 357 - 364
Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response Herman Andres PerroudCarlos Maria AlasinoO. Graciela Scharovsky Original Article 31 December 2015 Pages: 365 - 374
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients Rajiv KumarShir Kiong LuMary E. R. O’Brien Original Article 26 December 2015 Pages: 375 - 383
Pharmacokinetic interaction between pazopanib and cisplatin regimen Diane-Charlotte ImbsVéronique DiérasEtienne Chatelut Original Article 16 January 2016 Pages: 385 - 392
Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer Prasanna RajagopalanKhalid A. AlahmariHarish C. Chandramoorthy Original Article 18 January 2016 Pages: 393 - 404
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy Araz MarachelianAmi DesaiL. Mary Smith Original Article Open access 20 January 2016 Pages: 405 - 412
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study Miriam KönigCornelia von HagensSerkan Sertel Clinical Trial Report 21 January 2016 Pages: 413 - 427
Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression Jiřina MartínkováMilan BláhaStanislav Filip Short Communication 17 December 2015 Pages: 429 - 437
Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer Johanna C. BendellLee S. RosenManish R. Patel Erratum 20 November 2015 Pages: 439 - 439